Induction of transplantation tolerance by chimeric donor/recipient class I RT1.A(A) molecules

Transplantation

Volumn 62, Issue 7, 1996, Pages 1002-1010

  Ghobrial, Rafik R ^a   Hamashima, Takashi ^a   Wang, Mou Er ^a   Wang, Min ^a   Stepkowski, Stanislaw M ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; GRAFT REJECTION; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; IMMUNE TOLERANCE; ISOANTIGENS; MALE; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN STRUCTURE, SECONDARY; RATS; RATS, INBRED STRAINS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TRANSPLANTATION CHIMERA;

EID: 0029805828     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199610150-00020     Document Type: Article

References (72)

1. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance to foreign cells. Nature 1953; 172: 603.
2. Grossman Z. Cellular tolerance as a dynamic state of the adaptable lymphocytes. Immunol Rev 1993; 133: 45.
3. Dallman MJ, Wood KJ, Hamano K, et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133: 5.
4. Odorico JS, Posselt AM, Naji A, Markmann JF, Barker CF. Promotion of rat allograft survival by intrathymic inoculation of donor splenocytes. Transplantation 1993; 55: 1104.
5. Odorico JS, Barker CF, Posselt AM, Naji A. Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery 1992; 112: 370.
6. Hamashima T, Stepkowski SM, Smith S, Kahan BD. Induction of transplantation tolerance by a single injection of 3M KCl-extracted donor histocompatibility antigens combined with two doses of anti-rat α/β T cell receptor monoclonal antibodies. Transplantation 1994; 58: 105.
7. Bashell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. Transplantation 1994; 58: 133.
8. Perloff LJ, Baker CF. Variable response to donor-specific blood transfusion in the rat. Transplantation 1984; 38: 178.
9. Wood ML, Monaco AP, Gottschalk R. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice. Transplantation 1991; 51: 208.
10. Oluwole SF, Ng AK, Reemtsra K, Hardy M. The mechanism of the induction of immunologic unresponsiveness to rat cardiac allograft by recipient pretreatment with donor lymphocyte subsets. Transplantation 1991; 48: 28.
11. Myburgh JA, Smit JA. Prolongation of liver allograft survival by donor-specific soluble transplantation antigens and antigen-antibody complexes. Transplantation 1975; 19: 64.
12. Yasumura T, Kahan BD. Prolongation of rat kidney allograft by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. Transplantation 1983; 36: 603.
13. Didlake R, Kim EK, Kahan BD. Ability of 3M KCl-extracted histocompatibility antigen to potentiate the immunosuppressive effect of cyclosporine to prolong the survival of heterotopic rat cardiac allografts. Transplantation 1988; 46: 743.
14. Medawar PB. The use of antigenic tissue to weaken the immunological reaction against skin homografts in mice. Transplantation 1963; 1: 21.
15. Goto S, Stepkowski SM, Kahan BD. Benefit of multiple over single doses of 3M KCl-extracted histocompatibility antigen in the potentiating of cyclosporine-induced prolongation of rat cardiac allograft survival. Transplantation 1992; 53: 705.
16. Florence LS, Ito T, Ang KK, et al. The synergistic effect of total lymphoid irradiation with extracted donor alloantigen in inducing transplantation unresponsiveness. Transplantation 1989; 47: 156.
17. Ito T, Stepkowski SM, Kahan BD. Soluble antigen and cyclosporine-induced specific unresponsiveness in rats: frequency of alloantigen-specific T cytotoxic cells in normal, sensitized and unresponsive rats. Transplantation 1990; 49: 422.
18. Yoshimura N, Kahan BD. Nature of suppressor cells mediating prolonged graft survival after administration of extracted histocompatibility antigen and cyclosporine. Transplantation 1985; 39: 162.
19. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988; 332: 161.
20. Sayegh MH, Perico N, Gallon L, et al. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 1994; 58: 125.
21. Nisco S, Vriens P, Hoyt G, et al. Induction of allograft tolerance by an HLA class-I-derived peptide and cyclosporine A. J Immunol 1994; 152: 3786.
22. Bjorkman PJ, Parham P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990; 59: 253.
23. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen HLA-A2. Nature 1987; 329: 506.
24. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992; 70: 1035.
25. Silver ML, Guo HC, Strominger JL, Wiley DC. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992; 360: 367.
26. b at 2.4 A resolution: implications for antigen-determinant selection. Cell 1994; 76: 39.
27. Salter RD, Norment AM, Chen BP, et al. Polymorphism in the alpha 3 domain of HLA-A molecules affects binding to CD8. Nature 1989; 338: 345.
28. Gill TJ III, Kunz HW, Misra DN, Cortese Hassett AL. The major histocompatibility complex of the rat. Transplantation 1987; 43: 773.
29. Rada C, Lorenzi R, Powis SJ, Van Den Bogaerde J, Parham P, Howard JC. Concerted evolution of class I genes in the major histocompatibility complex of murine rodents. Proc Natl Acad Sci USA 1990; 87: 2167.
30. Mauxion F, Sobczak J, Kress M. Characterization of five distinct cDNA clones encoding for class I RT1 antigens. Immunogenetics 1989; 29: 397.
31. 1 and two other class I genes of the rat MHC. Immunogenetics 1995; 41: 375.
32. Wang M, Stepkowski SM, Tian L, Langowski JL, Yu J, Kahan BD. Nucleotide sequences of three distinct clones coding for rat heavy chain class I major histocompatibility antigens. Immunogenetics 1996; 43: 318
33. Guttmann RD, Forbes DC, Cramer DV, Gill TJ III. Cardiac allograft rejection and enhancement in natural recombinant rat strains. Transplantation 1980; 30: 216.
34. Alastair J, Bolton EM, Porteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp Med 1990; 172: 1547.
35. a, a class I major histocompatibility complex of the rat. Eur J Immunol 1984; 14: 405.
36. Fangmann J, Dalchau R, Fabre JW. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 1992; 175: 1521.
37. b alloantigen in vitro and in vivo. Transplant Proc 1993; 25: 481.
38. Clayberger C, Lyu SC, Pouletty P, Krensky AM. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. Transplant Proc 1993; 25: 477.
39. 2 domain of HLA-A2. Nature 1987; 325: 625.
40. Schneck J, Maloy WL, Coligan JE, Margulies DH. Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell 1989; 56: 47.
41. Gammon G, Shastri N, Cogswell J, et al. The choice of T cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as the determinant site. Immunol Rev 1987; 98: 53.
42. Sollinger AM, Ultee ME, Margoliash E, Shwartz RH. T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes. J Exp Med 1979; 150: 830.
43. Clayton JP, Gammon GY, Ando DG, Konon DH, Hood L, Sercarz E. Peptide-specific prevention of experimental allergic encephalomyelitis: neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med 1989; 169: 1681.
44. Berkower I, Matis LA, Buckenmeyer GK, Gurd FRN, Longo DL, Berzofsky JA. Identification of distinct predominant epitopes recognized by myoglobin-specific T-cells under control of different Ir genes and characterization of representative T-cell clones. J Immunol 1984; 132: 1370.
45. Liu Z, Williams KP, Chang YH, Smith JA. Immunodominance: a single amino acid substitution without an antigenic site alters intramolecular selection of T cell determinants. J Immunol 1993; 151: 1852.
46. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 1993; 363: 156.
47. Horton RM, Cai Z, Ho SN, Pease LR. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 1990; 8: 528.
48. Masuji H, Nakabayashi H, Sato J. Long-term cultivation of two diploid epithelial cell lines derived from normal rat liver cells. Acta Med Okayama 1974; 28: 281.
49. Felinger PL, Gadek TR, Holm M, et al. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413.
50. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 51: 225.
51. Reisfeld RA, Kahan BD. Biological and chemical characterization of human histocompatibility antigens. Fed Proc 1970; 29: 2034.
52. Sharwan H, Learner M, Wang HK, Makowka L, Cramer DV. Peptides derived from α-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4 and CD8 and B cell responses after cardiac allograft rejection. Transplantation 1995; 59: 401.
53. Benichou GE, Fredoseyeva PV, Lehmann CA, et al. Limited T cell response to donor MHC peptides during allograft rejection. J Immunol 1994; 153: 938.
54. Katz M, Maizels R, Wicker L, Miller A, Sercarz EE. Immunological focusing by the mouse MHC: mouse strains confronted with distantly related lysozymes confine their attention to a very few epitopes. Eur J Immunol 1982; 12: 535.
55. Zamvil SS, Mitchell DM, Moore AC, Kitamura K, Steinman L, Rothbard JB. T cell epitope of autoantigen myelin basic protein that induces encephalomyelitis. Nature 1986; 324: 258.
56. Holman JM, Todd R. Enhanced survival of heterotopic rat heart allografts with portal venous drainage. Transplantation 1989; 49: 229.
57. Kamei T, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. Surgery 1990; 108: 415.
58. Rubinstein D, Roska AK, Lipsky PE. Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogeneic T lymphocytes. J Immunol 1986; 137: 1803.
59. Kamei T, Callery MP, Flye MW. Kupffer cells blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990; 48: 393.
60. Shwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
61. Hall BM, Pearce NW, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cells and its mechanism of action. J Exp Med 1990; 171: 141.
62. Cobbald SP, Adams E, Marshall SE, Davis JD, Waldman H. Mechanism of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev 1996; 149: 5.
63. Rocken M, Shevach EM. Immune deviation: the third dimension of nondeletional T cell tolerance. Immunol Rev 1996; 149: 175.
64. Munn DH, Pressey J, Beall AC, Hudes R, Alderson MR. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages: a potential mechanism of antigen-specific peripheral lymphocyte deletion. J Immunol 1996; 156: 523.
65. Takeuchi T, Lowry RP, Konieczny B. Heart allograft in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
66. Wicker LS, Katz ME, Sercarz EE, Miller A. Immunodominant protein epitopes. I. Induction of suppression to hen egg-white lysozyme is obliterated by removal of the first three N-terminal amino acids. Eur J Immunol 1984; 14: 442.
67. Oki A, Sercarz EE. T cell tolerance studied at the level of antigen determinants. I. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice. J Exp Med 1985; 161: 897.
68. Saitovitch D, Morris PJ, Wood KJ. Donor-type single MHC locus products combined with anti-CD4 mAb induce tolerance to cardiac allografts which is independent on active suppression and independent of CD4+ T cells. Transplant Proc 1995; 27: 119.
69. Wood KJ, Evins J, Morris PJ. Suppression of renal allograft rejection in the rat by class I antigens or purified erythrocytes. Transplantation 1985; 39: 56.
70. Pouteil-Noble C, Wood KJ, Morris PJ. The effect of purified class II major histocompatibility complex antigen on the survival of vascularized organ allografts in the rat. Transplantation 1993; 55: 656.
71. Oluwole SF, Chowdhury NC, Fawwaz R. Induction of donor-specific unresponsiveness to rat cardiac allografts by intrathymic injection of UV-B-irradiated donor spleen cells. Transplantation 1993; 55: 1389.
72. Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R, Wolff J. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Transplantation 1994; 57: 990.